CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

The right ventricle in pulmonary hypertension Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Left main coronary artery compression in pulmonary hypertension Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Chronic thromboembolic pulmonary hypertension Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Sotatercept for the Treatment of Pulmonary Arterial Hypertension Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)

Clinical Case StudyAvailable online 23 April 2020

JOURNAL:Can J Cardiol. Article Link

Pulmonary Hypertension Caused by a Coconut Left Atrium

EC Leung, N Hirani et al. Keywords: pulmonary hypertention; coconut left atrium; chest x-ray image

ABSTRACT

“Coconut atrium” was first described in 1898 and is most commonly associated with rheumatic heart disease. This case demonstrates a dramatic chest x-ray image of extensive circumferential calcification of the left atrium. The abnormality was thought to result in elevated pulmonary pressures and severe right heart failure in the absence of significant mitral valve dysfunction.